Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

MACROGENICS INC Director's Dealing 2019

Feb 8, 2019

34129_dirs_2019-02-08_5b2714e2-0a2f-44b8-830d-88cd3b170525.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MACROGENICS INC (MGNX)
CIK: 0001125345
Period of Report: 2019-02-06

Reporting Person: Spitznagel Thomas (Sr VP, BPD & Manufacturing)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-02-06 Common Stock M 1770 $7.51 Acquired 1770 Direct
2019-02-06 Common Stock S 1770 $30 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-02-06 Employee stock option (right to buy) $7.51 M 1770 Disposed 2023-09-17 Common Stock (1770.0) Direct

Footnotes

F1: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2018.